On the alert.
D000081:Acetamides / Q000627:therapeutic use; D000367:Age Factors; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D006801:Humans; D017589:Immunization Programs; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000145:classification / Q000600:supply & distribution; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D018579:Patient Selection; D011159:Population Surveillance; D012299:Rimantadine / Q000627:therapeutic use; D012307:Risk Factors; D012794:Sialic Acids / Q000627:therapeutic use; D014481:United States
D000081:Acetamides; D000998:Antiviral Agents; D007252:Influenza Vaccines; D012794:Sialic Acids; D012299:Rimantadine; D000547:Amantadine; D009439:Neuraminidase